Am J Transplant, Volume 18, Suppl 3 Archives - Page 192 of 211 - ATC Abstracts

2018 American Transplant Congress
The Continuous Debate of Older Donors into Older Recipients: Another Angle
J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Heart transplantation (HTx) remains limited by donor availability. Many programs accept older donors (≥50 yrs) for older recipients (≥ 60 yrs) in an effort…
2018 American Transplant Congress
Outcomes of Subsequent Pregnancies in Female Heart Transplant Recipients
S. Rao,^1,2 D. Armenti,¹ L. Coscia,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
¹Transplant Pregnancy Registry International, Gift of Life Institute, Philadelphia, PA; ²Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ³Surgery, Lehigh Valley Health Network, Allentown, PA; ⁴Surgery, Morsani College of Medicine, Tampa, FL.
The purpose of this study is to analyze the maternal and newborn outcomes in successive pregnancies in female heart transplant recipients (HT) reported to the…
2018 American Transplant Congress
Incidence of Pneumonitis in Heart Transplant Patients Started on a Proliferation Signal Inhibitor
R. Levine, J. Patel, M. Levine, M. Kittleson, E. Kransdorf, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Proliferation signal inhibitors(PSI) have a high discontinuation rate due to side effects. PSI induced pneumonitis has been reported in 14% in renal cell carcinoma…
2018 American Transplant Congress
Ex-Vivo Pretreatment of Islets with Mitomycin-C Have a Potential to Induce Specific Immune Response for Peripheral Tolerance
N. Sato, A. Kenjo, T. Kimura, R. Okada, T. Ishigame, Y. Kofunato, J. Watanabe, M. Muto, S. Suzushino, T. Shimura, S. Marubashi.
Hepato-Biliary-Pancreatic and Transplant Sugery, Fukushima Medical University, Fukushima, Japan.
Background.Our previous study demonstrated that ex-vivo Mitomycin-C(MMC) pretreatment of islets reduced immunogenicity, enhancing graft survival without immunosuppression(IS). However, it is still unclear whether donor specific…
2018 American Transplant Congress
Transplant Benefit to Patients with Long Dialysis Vintage
A. Massie, D. Crews, T. Purnell, J. Garonzik-Wang, D. Segev.
Johns Hopkins, Baltimore.
Following implementation of KAS, deceased donor kidney transplant (DDKT) waitlist registrants with long dialysis vintage have high allocation priority. However, having survived for many years…
2018 American Transplant Congress
Should Kidneys from Donation after Cardiac Death Expanded Criteria Donors Be Transplanted?
D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Expanded criteria donor (ECD) kidneys increase the organ pool but their discard rate remains high, especially in the setting of donation after cardiac death…
2018 American Transplant Congress
A Meta-Analysis for Induction Therapy of Kidney Transplantation: Comparison of Antithymocyte Globulin and Interleukin 2 Receptor Antagonist
G. Chen, Z. Wu, C. Wang, X. Liu, C. Wang, L. Chen.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Objectives To compare the efficacy and safety of antithymocyte globulin (ATG) and interleukin 2 receptor antagonist (IL2Ra) in induction therapy of kidney transplantation.Method A literature…
2018 American Transplant Congress
Developing a Rationale for an Appropriate Immunosuppressive Regimen in Lung vs Kidney Transplant Recipients: Effects of Induction Therapy
P. Martin-Moreno,^1,2 H. Shin,^1,3 H. Goldberg,⁴ A. Chandraker.¹
¹Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; ²Nephrology Department, Clinica Universidad de Navarra, Pamplona, Spain; ³Renal Division, Department of Internal Medicine, Gospel Hospital, Kosin University College of Medicine, Busan, Korea; ⁴Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
IntroductionThe appropriate use of Thymoglobulin (ATG) or Basiliximab as induction therapy is not fully understood. We studied circulating cytokine profiles following kidney and lung transplantation…
2018 American Transplant Congress
Long-Term Renal Function in Living Kidney Donors with Renal Cysts
M. Waldram, A. Thomas, A. Muzaale, C. Holscher, A. Nguyen, S. Halpern, S. Anjum, J. Alejo, B. Boyarsky, S. Ottman, J. Garonzik-Wang, D. Segev, A. Massie.
JHU, Baltimore.
Renal cysts found during the evaluation of living kidney donor (LKD) candidates are often regarded as benign. However, it is possible that these structural abnormalities…
2018 American Transplant Congress
Objective Markers of Frailty Predict Successful Listing and Survival for Renal Transplant
A. Tevar, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, M. Molinari, A. Humar, Y. Wang, J. Steel.
Surgery, University of Pittsburgh, Pittsburgh, PA.
Background: Across all medical specialties, frailty has been shown to be a predictor of poor health outcomes. Previous studies have shown that gait speed and…